News
The Revell family hoped a gene therapy could buy time for their sons, who have a rare and fatal disease. After two patients ...
TipRanks on MSN19h
FDA investigating death of child who received Sarepta’s Elevidys
The U.S. FDA is investigating the death of an 8-year-old boy who received Elevidys, a Sarepta (SRPT) Therapeutics gene therapy for Duchenne ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback